2iqo
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| + | {{Theoretical_model}} | ||
| + | |||
==MODEL OF MU-OPIOID RECEPTOR IN ACTIVE STATE WITH AGONIST== | ==MODEL OF MU-OPIOID RECEPTOR IN ACTIVE STATE WITH AGONIST== | ||
<StructureSection load='2iqo' size='340' side='right' caption='[[2iqo]]' scene=''> | <StructureSection load='2iqo' size='340' side='right' caption='[[2iqo]]' scene=''> | ||
| Line 7: | Line 9: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| + | [[Category: Theoretical Model]] | ||
[[Category: Lomize, A L]] | [[Category: Lomize, A L]] | ||
[[Category: Pogozheva, I D]] | [[Category: Pogozheva, I D]] | ||
Revision as of 11:01, 11 February 2016
 |
MODEL OF MU-OPIOID RECEPTOR IN ACTIVE STATE WITH AGONIST
| |||||||||||
